THERAPEUTIC AGENT FOR PAIN
    4.
    发明申请
    THERAPEUTIC AGENT FOR PAIN 有权
    疼痛治疗剂

    公开(公告)号:US20130165491A1

    公开(公告)日:2013-06-27

    申请号:US13820873

    申请日:2010-09-06

    IPC分类号: C07D249/08 C07D403/04

    摘要: [Problem]Provided is a pharmaceutical, in particular, a pharmaceutical composition which is useful for the treatment of pain.[Means for Solution]The present inventors have made extensive studies using model animals with pain for the purpose of providing a therapeutic agent for pain. As a result, they have found that 11β-hydroxydehydrogenase type 1 (11β-HSD1) inhibitor, in particular, a triazole compound having a cyclic group at the 3-position (or 5-position) of a triazole ring has a good effect of ameliorating chronic pain. That is, according to the present invention, a pharmaceutical composition comprising an 11β-HSD1 inhibitor, in particular, the triazole compound of the present invention, as an active ingredient, is useful for the treatment of pain (particularly, neuropathic pain or fibromyalgia).

    摘要翻译: [问题]提供了一种药物,特别是可用于治疗疼痛的药物组合物。 [解决方案]本发明人为了提供疼痛治疗剂而对具有疼痛的模型动物进行了广泛的研究。 结果发现,1α-(11β-HSD1)抑制剂,特别是在三唑环3位(或5位)具有环状基团的三唑化合物具有良好的效果, 改善慢性疼痛。 也就是说,根据本发明,包含11beta-HSD1抑制剂,特别是本发明的三唑化合物作为活性成分的药物组合物可用于治疗疼痛(特别是神经性疼痛或纤维肌痛) 。

    Therapeutic agent for pain
    7.
    发明授权

    公开(公告)号:US09765040B2

    公开(公告)日:2017-09-19

    申请号:US13820873

    申请日:2011-09-06

    摘要: [Problem]Provided is a pharmaceutical, in particular, a pharmaceutical composition which is useful for the treatment of pain.[Means for Solution]The present inventors have made extensive studies using model animals with pain for the purpose of providing a therapeutic agent for pain. As a result, they have found that 11β-hydroxydehydrogenase type 1 (11β-HSD1) inhibitor, in particular, a triazole compound having a cyclic group at the 3-position (or 5-position) of a triazole ring has a good effect of ameliorating chronic pain. That is, according to the present invention, a pharmaceutical composition comprising an 11β-HSD1 inhibitor, in particular, the triazole compound of the present invention, as an active ingredient, is useful for the treatment of pain (particularly, neuropathic pain or fibromyalgia).